Researchers from the Illawarra Health and Medical Research Institute (IHMRI) have recently determined CBD isolate could treat the negative cognitive symptoms that coincide with schizophrenia, including social withdrawal and blunted emotional expression. The study, which was published in the journal Neuropsychopharmacology, involved using a rodent model of schizophrenia and comparing rats treated with CBD to those left untreated. The researchers found CBD restored cognition, working memory, and social behavior.
This information is significant considering past research has suggested cannabis actually heightened the risk of developing psychoses. University of Wollongong PhD candidate Ashleigh Osborne notes CBD may fill a void left by current antipsychotic medication treatments, explaining, "This is really important because current antipsychotic drugs don't address the cognitive deficits, which approximately 80 per cent of patients with schizophrenia experience... This is the first study to prove Cannabidiol can be used to treat symptoms of schizophrenia that aren't addressed by current medications."
Further research is desired to see if the results produced by he rodent model would translate to actual people suffering from schizophrenia. This information has been provided by Civilized and approved by our Chief Medical Officer.